aXichem AB (FRA:A6X)

Germany flag Germany · Delayed Price · Currency is EUR
0.168
-0.014 (-7.95%)
At close: Dec 4, 2025
90.91%
Market Cap 12.14M
Revenue (ttm) 1.45M
Net Income (ttm) -1.60M
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.168
Previous Close 0.183
Day's Range 0.168 - 0.168
52-Week Range 0.057 - 0.323
Beta n/a
RSI 38.78
Earnings Date Nov 28, 2025

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is b... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 7
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol A6X
Full Company Profile

Financial Performance

In 2024, aXichem AB's revenue was 8.57 million, an increase of 373.74% compared to the previous year's 1.81 million. Losses were -17.81 million, -14.41% less than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.